Deutsche Biotech Innovativ AG
Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.
DBI | F
Overview
Corporate Details
- ISIN(s):
- DE000A0Z25L1
- LEI:
- 391200BIDNL2ZOKI1M61
- Country:
- Germany
- Address:
- Neuendorfstraße 15a, 16761 Hennigsdorf
- Website:
- https://www.dbi-ag.de/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Deutsche Biotech Innovativ AG is a biotechnology company focused on the research and clinical development of therapeutic solutions for serious diseases with high unmet medical needs. The company leverages an innovative approach centered on blood biomarkers to identify and develop its drug candidates. Its portfolio includes Adrecizumab, an antibody-based therapy that has undergone clinical trials for the treatment of septic shock. DBI's strategy combines the development of both therapeutics and diagnostic biomarkers to address therapeutic challenges.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-18 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
|
German | 22.7 KB | ||
| 2025-09-29 00:00 |
Annual / Quarterly Financial Statement
Datum:29.09.2025
|
German | 31.8 KB | ||
| 2024-10-07 00:00 |
Annual Report
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 28.4 KB | ||
| 2023-12-20 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 27.5 KB | ||
| 2023-09-20 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 15.1 KB | ||
| 2022-11-07 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
|
German | 19.0 KB | ||
| 2022-07-19 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
|
German | 29.0 KB | ||
| 2022-04-21 10:27 |
Regulatory News Service
Deutsche Biotech Innovativ AG: Paul-Ehrlich Institut-(PEI)-Zulassung fur eine d…
|
German | 33.0 KB | ||
| 2021-09-03 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
|
German | 28.3 KB | ||
| 2021-08-30 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
|
German | 14.6 KB | ||
| 2021-02-04 20:01 |
Board/Management Information
Deutsche Biotech Innovativ AG: Veranderungen in Vorstand und Aufsichtsrat
|
German | 5.4 KB | ||
| 2020-12-14 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
|
German | 14.8 KB | ||
| 2020-09-16 06:30 |
Earnings Release
Deutsche Biotech Innovativ AG: * Positive Ergebnisse der Phase-II-Studie Adreno…
|
German | 6.5 KB | ||
| 2020-08-25 10:58 |
Earnings Release
Deutsche Biotech Innovativ AG: Barrier function of blood vessels as therapeutic…
|
English | 7.5 KB | ||
| 2020-08-19 14:00 |
Major Shareholding Notification
Deutsche Biotech Innovativ AG: Further step towards a strong capital market ori…
|
English | 7.6 KB |
Automate Your Workflow. Get a real-time feed of all Deutsche Biotech Innovativ AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Deutsche Biotech Innovativ AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Deutsche Biotech Innovativ AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
